A research team has identified different subtypes of white matter (WM) astrocytes, including a unique type with the ability ...

Cataract surgery was associated with an increased risk of worsening diabetic retinopathy in adults with type 2 diabetes, ...

A research team led by Dr. Judith Fischer-Sternjak from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) München, alongside Prof. Magdalena ...

Obinutuzumab B-cell depleting therapy is more effective than standard care in treating patients with active proliferative lupus nephritis.

Cancer represents a hallmark human disorder of the 21st century. The disease has been around for so long and yet its early diagnosis, let alone its definitive therapy has remained elusive. While ...

Scientist Paul Helfrich has studied the T. bryo fish parasite for years and remains fascinated by its life cycle and ...

Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical development of its lead experimental drug, AUTX-703, in blood cancers.

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

The growth of the finance sector is marked by the proliferative adoption of advanced technology, including cloud computing, robotic process automation, machine learning, and artificial intelligence.

Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...